SlideShare a Scribd company logo
1 of 69
LOCAL ANAESTHETICS BY :DR SUHAIMI TAJUDIN MODERATOR : PROF MADYA DR SHAMSUL HUSM ANESTESIOLOGI DEPARTMENT
OUTLINE Introduction Ideal properties Comercial preparation Structure activity relationship Mechanism of action Pharmacokinetic Side effects Individual LA
INTRODUCTION ,[object Object]
Without loss of consciousness and reversible,[object Object]
3. Commercial Preparations Poorly soluble in water – marketed most often as water-soluble hydrochloride salt These HCl salts are acidic(pH 6) – contributing to the stability of LA  An acidic pH also important if epinephrine is present in LA solution, becoz this cathecolamine is unstable at alkaline pH sodium metabisulphite (strongly acidic), may be added to LA-ephephrine solutions to prevent oxidative decomposition of epinephrine
COMERCIAL PREPARATION Alkalinization of LA solution By adding sodium bicarbonate Will shortens the onset (more nonionized form) Enhance dept of sensory and motor blockade (increase potency) Increase spread of epidural blockade
4.Structure Activity Relationship  LIPOPHILIC PORTION HYDROPHILIC PORTION HYDROCARBON CHAIN
4. cont… ,[object Object]
Usually unsaturated aromatic ring e.gpara-aminobenzoic acid
lipid soluble
Potency
Hydrophilic portion
Is usually tertiary amine
Water soluble
Connecting hydrocarbon chains			.ester( -CO.O-) 			.amide(-NH.CO) 	the nature of this bond is the basis of classification of LA, relate to site of metabolism and potential to produce allergic reaction
Comparison  ,[object Object]
( -CO.O-)
Procaine, tetracaine, amethocaine, cocaine
Relatively unstable in solution
Allergic reactions are common
Rapidly metabolised by plasma and liver cholinesterase
One metabolite, para-aminobenzoic acid, thought to be responsible for allergic rxn
Metabolism may be prolonged when pl cholinesterase is low
E.g liver disease, pregnancy and atypical enzymes
Amides
(-NH.CO)
lignocaine, etidocaine, prilocaine, mepivacaine, bupivacaine,ropivacaine, levobupivacaine
Relatively stable in solution
Allergic reaction is rare, may be ass with preservative vehicle
Slowly metabolised by amidases in  liver
Dependent on liver blood flow and function,[object Object]
RESTING MEMBRANE POTENTIAL ,[object Object]
About 70mV with the inside membrane being negative compare to outside
The Na-K-ATPase is electrogenic , pumps 3Na out of cell in exchange for 2K pumped intracellularly. This pump sets up concentration different of Na & K across the cell membrane
small net intracellular loss of +ve charge
The membrane is permeable to Na and K, so these ion tend to leak across membrane down their concentration gradient
membrane is 100x more permeable to K, > K lost from cell than Na enters the cellNet result is larger amt of +ve charge left the cell than has entered it so inside of membrane left with net negative charge  result in RMP are being negative compare to outside
ACTION POTENTIAL ,[object Object]
Last only 1-2ms
Electrical or chemical trigger initially cause slow rise in membrane potential until threshold potential (50mV) is reached
Voltage sensitive Na channels then open, increasing Na pemeability dramatically and membrane potential briefly reaches +30mV, at which Na channels close
The membrane potential return to its resting value with an increased efflux of K
The Na/K ATPase restores the concentration gradients,[object Object]
Mechanism of action LA selectively binds to Na channel in inactivated-closed state.  It stabilizes it in this configuration and prevent their change to rested-closed and activated-open states in response to nerve impulse Na channel impermeable to Na Slows the rate of depolarisation, threshold potential not reached & action potential not propagated
Frequency- dependent blockade Defines a situation where the more frequent the channel  are activated, the greater the degree of block produced  After AP, Na channel develop a low affinity state where some drugs dissociate/ unbind and Na channel recover  If another AP arrived before all LA dissociates it regain access into the Na channel at open activated state  -> additional increment of block ↑ Frequency of AP - ↑ degree of blockade
Membrane volume expansion theory Lipophilic LA incorporated into lipid bilayer causing a volume expansion & distortion to the conformation of axonal membrane and hence the Na channel resulting in its inactivation Mode of action of Benzocaine, and other LA when given in high dosage
6.PHARMACOKINETIC Physicochemical properties Absorption Distribution Metabolism Excretion
PHYSICOHEMICAL PROPERTIES The chemical structure and physicochemical characteristics of LA affect their clinical properties  Modification of the chemical structure (lengthening of the hydrocarbon  chain within critical length or increasing the number of carbon atoms in the aromatic ring or tertiary amine ) may alter lipid solubility, potency, rate of metabolism & duration of action In particular, these are modified by Lipid solubility Protein binding Dissociation constant (pKa value)
a) Lipid solubility  Lipid solubility of different anaesthetics governs their ability to penetrate perineuronal tissues and neural membrane, and reaches their site of action in neuroplasm More lipid soluble – penetrates membrane more easily, less molecule requires for nerve conduction blockade i.e. more potent E.g. Bupivacaine, levobupivacaine and ropivacaine are app 3-4x as potent as lidocaine or prilocaine, dt differences in their lipid-solubility
Physicochemical properties
b) Protein binding Tissue protein binding primarily affect  the duration of axn of LA ,[object Object]
Plasma protein binding acts as  depotE.g Procaine is not extensively bound to tissue protein, has short duration of action Bupivacaine, levobupivacaine & ropivacaine are extensively bound to plasma and tissue protein --- prolonged effect
Physicochemical properties
c) Dissociation constant (pKa value) pKa is equal to pH at which the concentration of ionized base  and non-ionized base are equal Is the most important factor affecting rapidity of onset of axn pKa value governs the proportions of LA that is present in non-ionized form at physiological pH values and therefore available to diffuse across tissue barrier to its site of axn LA with a pKa near physiological pH will have a greater degree of unionized molecules -> More LA diffused across membrane  -> rapid onset of action
Physicochemical properties
ABSORPTION Absorption of LA from its site of injection into systemic circulation is influenced by; Site of injection Dosage Addition of vasoconstrictor Physicochemical properties of LA Vasoactive properties of the LA Pathophysiological process – acidity of tissue reduces absorption ( e.g. abscess, metabolic acidosis)
Site of injection ,[object Object]
Blood concentration in decreasing order
Intercostal > caudal > epidural > brachial plexus > sciatic-femoral > subcutaneous infiltrationDosage ,[object Object]
Linear relationship between total dose & peak blood conc achieved,[object Object]
c. Addition of vasoconstrictor By addition of adrenaline 5g/ml (1:200000) Higher Dosage offers no additional benefits but increases symphatomimetic activites  limit systemic absorption and maintain the drug concentration in nerve fibre and prolong the time the drug in contact with nerve fibre Ropivacaine & Cocaine has intrinsic vasoconstrictor activities Lignocaine, mepivacaine, bupivacaine, etidocaine exhibit vasodilator effects
Vasoactive properties of LA Influence potency and duration of action All LA has vasodilator effect except ropivacaine and coccaine More vasoactive like lidocaine more greater systemic absorption result in shorter duration of action Pathophysiological process Acidosis environment  Will increase ionized fraction of the drug Result in poor quality of LA Physiocochemical properties Lipid solubility Protein binding Dissociation constant
DISTRIBUTION ,[object Object],a)Tissue perfusion  ,[object Object]
Followed by slower redistribution to moderately profused tissue (muscle&gut)b) Protein binding	 ,[object Object]
Influence by changes in conc. of alpha1 acid glycoprotein (eg; pregnancy,old age, concurrent Liver Disease)c)  high lipid solubility; facilitates tissue uptake d) Tissue mass ,[object Object],	overall amide are more widely distributed in tissue than ester group
  Lung extraction The lung capable of extracting local anesthetic such as lidocaine and bupivacaine from circulation Limit the concentration of drug that reaches systemic circulation to be distributed to coronary & cerebral circulation Placental transfer Highly  plasma protein binding LA limits diffusion across placenta Esters undergo rapid hydrolysis hence not available for transfer across placenta Acidosis in fetus, which may occur during prolonged labour, can result in accumulation of LA molecules in the fetus (ion trapping)
METABOLISM a) ESTER group ,[object Object]
Rate of hydrolysis varies, and resulting metabolites are pharmacologically inactive
Paraaminobenzoic acid metabolite may be responsible for  allergic reaction

More Related Content

What's hot

Chem 45 Biochemistry: Stoker Chapter 21 Enzymes & Vitamins
Chem 45 Biochemistry: Stoker Chapter 21 Enzymes & VitaminsChem 45 Biochemistry: Stoker Chapter 21 Enzymes & Vitamins
Chem 45 Biochemistry: Stoker Chapter 21 Enzymes & VitaminsShaina Mavreen Villaroza
 
GPCRs and their second messengers
GPCRs and their second messengersGPCRs and their second messengers
GPCRs and their second messengersFasika Argaw
 
Slideshare second messengers aj
Slideshare second messengers ajSlideshare second messengers aj
Slideshare second messengers ajAnu Priya
 
Diacylglycerol signaling pathway
Diacylglycerol           signaling pathwayDiacylglycerol           signaling pathway
Diacylglycerol signaling pathwayyonas teshome
 
Summary of metabolism lecture
Summary of metabolism lectureSummary of metabolism lecture
Summary of metabolism lectureDr. Armaan Singh
 
Secondary messengers system
Secondary messengers systemSecondary messengers system
Secondary messengers systemFoziyaKhan
 
ROLE OF SECOND MESSENGERS IN RECEPTOR SIGNAL TRABSDUCTION
ROLE OF SECOND MESSENGERS IN RECEPTOR SIGNAL TRABSDUCTION ROLE OF SECOND MESSENGERS IN RECEPTOR SIGNAL TRABSDUCTION
ROLE OF SECOND MESSENGERS IN RECEPTOR SIGNAL TRABSDUCTION Priyansha Singh
 
Chapter 15 - principle of metabolic regulation - Biochemistry
Chapter 15 - principle of metabolic regulation - BiochemistryChapter 15 - principle of metabolic regulation - Biochemistry
Chapter 15 - principle of metabolic regulation - BiochemistryAreej Abu Hanieh
 
IVMS LEARNING OUTCOMES -HORIZONTALLY INTEGRATED RAPID OVERVIEW
IVMS LEARNING OUTCOMES -HORIZONTALLY INTEGRATED RAPID OVERVIEWIVMS LEARNING OUTCOMES -HORIZONTALLY INTEGRATED RAPID OVERVIEW
IVMS LEARNING OUTCOMES -HORIZONTALLY INTEGRATED RAPID OVERVIEWImhotep Virtual Medical School
 
Peptides and proteins structure and functions
Peptides and proteins    structure and functionsPeptides and proteins    structure and functions
Peptides and proteins structure and functionsRamesh Gupta
 
Assignment on Secondary messengers and intracellular signaling
Assignment on Secondary messengers and intracellular signalingAssignment on Secondary messengers and intracellular signaling
Assignment on Secondary messengers and intracellular signalingDeepak Kumar
 
Over view of lac I [inhibitor]
Over view of lac I [inhibitor]Over view of lac I [inhibitor]
Over view of lac I [inhibitor]Nethravathi Siri
 
Post translational modification
Post translational modificationPost translational modification
Post translational modificationIqra Jr
 
Receptors and signal transduction
Receptors and signal transductionReceptors and signal transduction
Receptors and signal transductionaljeirou
 

What's hot (20)

Chem 45 Biochemistry: Stoker Chapter 21 Enzymes & Vitamins
Chem 45 Biochemistry: Stoker Chapter 21 Enzymes & VitaminsChem 45 Biochemistry: Stoker Chapter 21 Enzymes & Vitamins
Chem 45 Biochemistry: Stoker Chapter 21 Enzymes & Vitamins
 
enzyme regulation
enzyme regulationenzyme regulation
enzyme regulation
 
Enzymes
EnzymesEnzymes
Enzymes
 
GPCRs and their second messengers
GPCRs and their second messengersGPCRs and their second messengers
GPCRs and their second messengers
 
Slideshare second messengers aj
Slideshare second messengers ajSlideshare second messengers aj
Slideshare second messengers aj
 
Enzyme regulation
Enzyme regulationEnzyme regulation
Enzyme regulation
 
Diacylglycerol signaling pathway
Diacylglycerol           signaling pathwayDiacylglycerol           signaling pathway
Diacylglycerol signaling pathway
 
Summary of metabolism lecture
Summary of metabolism lectureSummary of metabolism lecture
Summary of metabolism lecture
 
Secondary messengers system
Secondary messengers systemSecondary messengers system
Secondary messengers system
 
Protein Kinase A
Protein Kinase AProtein Kinase A
Protein Kinase A
 
Signal tranduction.
Signal tranduction.Signal tranduction.
Signal tranduction.
 
ROLE OF SECOND MESSENGERS IN RECEPTOR SIGNAL TRABSDUCTION
ROLE OF SECOND MESSENGERS IN RECEPTOR SIGNAL TRABSDUCTION ROLE OF SECOND MESSENGERS IN RECEPTOR SIGNAL TRABSDUCTION
ROLE OF SECOND MESSENGERS IN RECEPTOR SIGNAL TRABSDUCTION
 
Chapter 15 - principle of metabolic regulation - Biochemistry
Chapter 15 - principle of metabolic regulation - BiochemistryChapter 15 - principle of metabolic regulation - Biochemistry
Chapter 15 - principle of metabolic regulation - Biochemistry
 
IVMS LEARNING OUTCOMES -HORIZONTALLY INTEGRATED RAPID OVERVIEW
IVMS LEARNING OUTCOMES -HORIZONTALLY INTEGRATED RAPID OVERVIEWIVMS LEARNING OUTCOMES -HORIZONTALLY INTEGRATED RAPID OVERVIEW
IVMS LEARNING OUTCOMES -HORIZONTALLY INTEGRATED RAPID OVERVIEW
 
Peptides and proteins structure and functions
Peptides and proteins    structure and functionsPeptides and proteins    structure and functions
Peptides and proteins structure and functions
 
Assignment on Secondary messengers and intracellular signaling
Assignment on Secondary messengers and intracellular signalingAssignment on Secondary messengers and intracellular signaling
Assignment on Secondary messengers and intracellular signaling
 
Summary of metabolism
Summary of metabolismSummary of metabolism
Summary of metabolism
 
Over view of lac I [inhibitor]
Over view of lac I [inhibitor]Over view of lac I [inhibitor]
Over view of lac I [inhibitor]
 
Post translational modification
Post translational modificationPost translational modification
Post translational modification
 
Receptors and signal transduction
Receptors and signal transductionReceptors and signal transduction
Receptors and signal transduction
 

Similar to La

LOCAL ANAESTHETIC 1.pptx
LOCAL ANAESTHETIC  1.pptxLOCAL ANAESTHETIC  1.pptx
LOCAL ANAESTHETIC 1.pptxDrVANDANA17
 
Pharmacology of local anaesthetics
Pharmacology of local anaestheticsPharmacology of local anaesthetics
Pharmacology of local anaestheticsDr. Vishal Pawar
 
Local anesthetics NIYAZ PV
Local anesthetics NIYAZ PVLocal anesthetics NIYAZ PV
Local anesthetics NIYAZ PVniyazpv
 
1647705503939_local anaesthesia.pptx
1647705503939_local anaesthesia.pptx1647705503939_local anaesthesia.pptx
1647705503939_local anaesthesia.pptxdrrajugandham1
 
local anesthetics pharmacology
local anesthetics pharmacologylocal anesthetics pharmacology
local anesthetics pharmacologysugamadex
 
LOCAL ANESTHESIA AND ANATOMICAL LANDMARKS
LOCAL ANESTHESIA AND ANATOMICAL LANDMARKSLOCAL ANESTHESIA AND ANATOMICAL LANDMARKS
LOCAL ANESTHESIA AND ANATOMICAL LANDMARKSAnushri Gupta
 
Local anesthesis
Local anesthesisLocal anesthesis
Local anesthesissachu12
 
Pharmacology of Local Anesthetics
Pharmacology of Local AnestheticsPharmacology of Local Anesthetics
Pharmacology of Local AnestheticsIAU Dent
 
neurophysiology and drugs of la
neurophysiology and drugs of laneurophysiology and drugs of la
neurophysiology and drugs of laJosephine Shamira
 
10. Local anaesthetics [Autosaved].pptx
10. Local anaesthetics [Autosaved].pptx10. Local anaesthetics [Autosaved].pptx
10. Local anaesthetics [Autosaved].pptxCarlAmonOcholla
 
Local anaesthetics
Local anaestheticsLocal anaesthetics
Local anaestheticsGaurav Joshi
 

Similar to La (20)

LOCAL ANESTH.pptx
LOCAL ANESTH.pptxLOCAL ANESTH.pptx
LOCAL ANESTH.pptx
 
LOCAL ANAESTHETIC 1.pptx
LOCAL ANAESTHETIC  1.pptxLOCAL ANAESTHETIC  1.pptx
LOCAL ANAESTHETIC 1.pptx
 
L a agents
L a agentsL a agents
L a agents
 
L a agents
L a agentsL a agents
L a agents
 
Local Anesthetic drugs
Local Anesthetic drugsLocal Anesthetic drugs
Local Anesthetic drugs
 
Local anaesthesia
Local anaesthesiaLocal anaesthesia
Local anaesthesia
 
Pharmacology of local anaesthetics
Pharmacology of local anaestheticsPharmacology of local anaesthetics
Pharmacology of local anaesthetics
 
Local anesthetics NIYAZ PV
Local anesthetics NIYAZ PVLocal anesthetics NIYAZ PV
Local anesthetics NIYAZ PV
 
1647705503939_local anaesthesia.pptx
1647705503939_local anaesthesia.pptx1647705503939_local anaesthesia.pptx
1647705503939_local anaesthesia.pptx
 
local anesthetics pharmacology
local anesthetics pharmacologylocal anesthetics pharmacology
local anesthetics pharmacology
 
Absorption of drug
Absorption of drugAbsorption of drug
Absorption of drug
 
Local Anaesthesia
Local AnaesthesiaLocal Anaesthesia
Local Anaesthesia
 
Local anaesthetics pharmacology
Local anaesthetics pharmacologyLocal anaesthetics pharmacology
Local anaesthetics pharmacology
 
LOCAL ANESTHESIA AND ANATOMICAL LANDMARKS
LOCAL ANESTHESIA AND ANATOMICAL LANDMARKSLOCAL ANESTHESIA AND ANATOMICAL LANDMARKS
LOCAL ANESTHESIA AND ANATOMICAL LANDMARKS
 
Local Anaesthesia By Dr Sardar Saud Abbas
Local Anaesthesia By Dr Sardar Saud AbbasLocal Anaesthesia By Dr Sardar Saud Abbas
Local Anaesthesia By Dr Sardar Saud Abbas
 
Local anesthesis
Local anesthesisLocal anesthesis
Local anesthesis
 
Pharmacology of Local Anesthetics
Pharmacology of Local AnestheticsPharmacology of Local Anesthetics
Pharmacology of Local Anesthetics
 
neurophysiology and drugs of la
neurophysiology and drugs of laneurophysiology and drugs of la
neurophysiology and drugs of la
 
10. Local anaesthetics [Autosaved].pptx
10. Local anaesthetics [Autosaved].pptx10. Local anaesthetics [Autosaved].pptx
10. Local anaesthetics [Autosaved].pptx
 
Local anaesthetics
Local anaestheticsLocal anaesthetics
Local anaesthetics
 

Recently uploaded

Science 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsScience 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsKarinaGenton
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityGeoBlogs
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxGaneshChakor2
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3JemimahLaneBuaron
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsanshu789521
 
Solving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxSolving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxOH TEIK BIN
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13Steve Thomason
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAssociation for Project Management
 
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Sapana Sha
 
MENTAL STATUS EXAMINATION format.docx
MENTAL     STATUS EXAMINATION format.docxMENTAL     STATUS EXAMINATION format.docx
MENTAL STATUS EXAMINATION format.docxPoojaSen20
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionSafetyChain Software
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeThiyagu K
 
_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting Data_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting DataJhengPantaleon
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxNirmalaLoungPoorunde1
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)eniolaolutunde
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingTechSoup
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentInMediaRes1
 
Crayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon ACrayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon AUnboundStockton
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...Marc Dusseiller Dusjagr
 

Recently uploaded (20)

Science 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsScience 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its Characteristics
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptx
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha elections
 
Solving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxSolving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptx
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across Sectors
 
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
 
MENTAL STATUS EXAMINATION format.docx
MENTAL     STATUS EXAMINATION format.docxMENTAL     STATUS EXAMINATION format.docx
MENTAL STATUS EXAMINATION format.docx
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory Inspection
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 
_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting Data_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting Data
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptx
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media Component
 
Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1
 
Crayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon ACrayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon A
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
 

La

  • 1. LOCAL ANAESTHETICS BY :DR SUHAIMI TAJUDIN MODERATOR : PROF MADYA DR SHAMSUL HUSM ANESTESIOLOGI DEPARTMENT
  • 2. OUTLINE Introduction Ideal properties Comercial preparation Structure activity relationship Mechanism of action Pharmacokinetic Side effects Individual LA
  • 3.
  • 4.
  • 5. 3. Commercial Preparations Poorly soluble in water – marketed most often as water-soluble hydrochloride salt These HCl salts are acidic(pH 6) – contributing to the stability of LA An acidic pH also important if epinephrine is present in LA solution, becoz this cathecolamine is unstable at alkaline pH sodium metabisulphite (strongly acidic), may be added to LA-ephephrine solutions to prevent oxidative decomposition of epinephrine
  • 6. COMERCIAL PREPARATION Alkalinization of LA solution By adding sodium bicarbonate Will shortens the onset (more nonionized form) Enhance dept of sensory and motor blockade (increase potency) Increase spread of epidural blockade
  • 7. 4.Structure Activity Relationship LIPOPHILIC PORTION HYDROPHILIC PORTION HYDROCARBON CHAIN
  • 8.
  • 9. Usually unsaturated aromatic ring e.gpara-aminobenzoic acid
  • 15. Connecting hydrocarbon chains .ester( -CO.O-) .amide(-NH.CO) the nature of this bond is the basis of classification of LA, relate to site of metabolism and potential to produce allergic reaction
  • 16.
  • 21. Rapidly metabolised by plasma and liver cholinesterase
  • 22. One metabolite, para-aminobenzoic acid, thought to be responsible for allergic rxn
  • 23. Metabolism may be prolonged when pl cholinesterase is low
  • 24. E.g liver disease, pregnancy and atypical enzymes
  • 27. lignocaine, etidocaine, prilocaine, mepivacaine, bupivacaine,ropivacaine, levobupivacaine
  • 29. Allergic reaction is rare, may be ass with preservative vehicle
  • 30. Slowly metabolised by amidases in liver
  • 31.
  • 32.
  • 33. About 70mV with the inside membrane being negative compare to outside
  • 34. The Na-K-ATPase is electrogenic , pumps 3Na out of cell in exchange for 2K pumped intracellularly. This pump sets up concentration different of Na & K across the cell membrane
  • 35. small net intracellular loss of +ve charge
  • 36. The membrane is permeable to Na and K, so these ion tend to leak across membrane down their concentration gradient
  • 37. membrane is 100x more permeable to K, > K lost from cell than Na enters the cellNet result is larger amt of +ve charge left the cell than has entered it so inside of membrane left with net negative charge result in RMP are being negative compare to outside
  • 38.
  • 40. Electrical or chemical trigger initially cause slow rise in membrane potential until threshold potential (50mV) is reached
  • 41. Voltage sensitive Na channels then open, increasing Na pemeability dramatically and membrane potential briefly reaches +30mV, at which Na channels close
  • 42. The membrane potential return to its resting value with an increased efflux of K
  • 43.
  • 44. Mechanism of action LA selectively binds to Na channel in inactivated-closed state. It stabilizes it in this configuration and prevent their change to rested-closed and activated-open states in response to nerve impulse Na channel impermeable to Na Slows the rate of depolarisation, threshold potential not reached & action potential not propagated
  • 45. Frequency- dependent blockade Defines a situation where the more frequent the channel are activated, the greater the degree of block produced After AP, Na channel develop a low affinity state where some drugs dissociate/ unbind and Na channel recover If another AP arrived before all LA dissociates it regain access into the Na channel at open activated state -> additional increment of block ↑ Frequency of AP - ↑ degree of blockade
  • 46. Membrane volume expansion theory Lipophilic LA incorporated into lipid bilayer causing a volume expansion & distortion to the conformation of axonal membrane and hence the Na channel resulting in its inactivation Mode of action of Benzocaine, and other LA when given in high dosage
  • 47. 6.PHARMACOKINETIC Physicochemical properties Absorption Distribution Metabolism Excretion
  • 48. PHYSICOHEMICAL PROPERTIES The chemical structure and physicochemical characteristics of LA affect their clinical properties Modification of the chemical structure (lengthening of the hydrocarbon chain within critical length or increasing the number of carbon atoms in the aromatic ring or tertiary amine ) may alter lipid solubility, potency, rate of metabolism & duration of action In particular, these are modified by Lipid solubility Protein binding Dissociation constant (pKa value)
  • 49. a) Lipid solubility Lipid solubility of different anaesthetics governs their ability to penetrate perineuronal tissues and neural membrane, and reaches their site of action in neuroplasm More lipid soluble – penetrates membrane more easily, less molecule requires for nerve conduction blockade i.e. more potent E.g. Bupivacaine, levobupivacaine and ropivacaine are app 3-4x as potent as lidocaine or prilocaine, dt differences in their lipid-solubility
  • 51.
  • 52. Plasma protein binding acts as depotE.g Procaine is not extensively bound to tissue protein, has short duration of action Bupivacaine, levobupivacaine & ropivacaine are extensively bound to plasma and tissue protein --- prolonged effect
  • 54. c) Dissociation constant (pKa value) pKa is equal to pH at which the concentration of ionized base and non-ionized base are equal Is the most important factor affecting rapidity of onset of axn pKa value governs the proportions of LA that is present in non-ionized form at physiological pH values and therefore available to diffuse across tissue barrier to its site of axn LA with a pKa near physiological pH will have a greater degree of unionized molecules -> More LA diffused across membrane -> rapid onset of action
  • 56. ABSORPTION Absorption of LA from its site of injection into systemic circulation is influenced by; Site of injection Dosage Addition of vasoconstrictor Physicochemical properties of LA Vasoactive properties of the LA Pathophysiological process – acidity of tissue reduces absorption ( e.g. abscess, metabolic acidosis)
  • 57.
  • 58. Blood concentration in decreasing order
  • 59.
  • 60.
  • 61. c. Addition of vasoconstrictor By addition of adrenaline 5g/ml (1:200000) Higher Dosage offers no additional benefits but increases symphatomimetic activites limit systemic absorption and maintain the drug concentration in nerve fibre and prolong the time the drug in contact with nerve fibre Ropivacaine & Cocaine has intrinsic vasoconstrictor activities Lignocaine, mepivacaine, bupivacaine, etidocaine exhibit vasodilator effects
  • 62. Vasoactive properties of LA Influence potency and duration of action All LA has vasodilator effect except ropivacaine and coccaine More vasoactive like lidocaine more greater systemic absorption result in shorter duration of action Pathophysiological process Acidosis environment Will increase ionized fraction of the drug Result in poor quality of LA Physiocochemical properties Lipid solubility Protein binding Dissociation constant
  • 63.
  • 64.
  • 65.
  • 66. Lung extraction The lung capable of extracting local anesthetic such as lidocaine and bupivacaine from circulation Limit the concentration of drug that reaches systemic circulation to be distributed to coronary & cerebral circulation Placental transfer Highly plasma protein binding LA limits diffusion across placenta Esters undergo rapid hydrolysis hence not available for transfer across placenta Acidosis in fetus, which may occur during prolonged labour, can result in accumulation of LA molecules in the fetus (ion trapping)
  • 67.
  • 68. Rate of hydrolysis varies, and resulting metabolites are pharmacologically inactive
  • 69. Paraaminobenzoic acid metabolite may be responsible for allergic reaction
  • 70. CSF – lacks estrase enzyme; so the termination of action of intrathecal injection of LA depends on absorption into bld. Stream
  • 71.
  • 72.
  • 73. EXCRETION Poor water solubility of LA limit renal excretion of unchanged drugs to < 5% of injected dose (except cocaine 10-12%) Water soluble para-aminobenzoic acid readily excreted
  • 74.
  • 77. TNS
  • 81. Blood
  • 85. Git
  • 86.
  • 87.
  • 88. As the plasma concentration increased, LA readily cross the BBB and produce cns changes
  • 89. Restlessness, vertigo, tinnitus and difficulty in focusing
  • 90. Slurred speech and skeletal muscle twiching- face and extremities
  • 91. Seizures and CNS depression
  • 92. Plasma concentration of LA depend on specific drug involve
  • 95.
  • 96. Convulsions should be treated by maintaning adequate ventilation and oxygenation, and controlled by anticonvulsant drugs
  • 99. Accidental injection of large vol of LA into CSF during epidural or paravertebral block can produce total SA
  • 100.
  • 102. Ass with use of vasoconstrictor
  • 103.
  • 105. Bowel and bladder sphincter dysfunction
  • 107. Following repeated doses of 5% lidocaine & 0.5% tetracaine used in continuous spinal anesthesia
  • 108.
  • 109. CVS Overdose of LA may cause profound hypotension, bradycardia, bradyarhythmias and even cardiac arrest, and usually follows sign of CNS toxicity E.g. – high systemic conc of bupivacaine are particularly ass with significant toxicity Produce prolonged blockade of Na channel also affects myocardial Ca and K channels, and is preferentially bound by cardiac muscle Myocardial contractility and conduction in junctional tissue is depressed, with widening of QRS complex and distortion of St segment
  • 110. Predispose to re-entrant phenomena and ventricular arrthyhmias, which are potentiated by hypoxia, acidosis and hyperK Arrthyhmias and bradycardia may respond to iv atropine (1.2-1.8mg) and colloid/crystalloid infusions may be required to expand pl vol Current evidence suggest that use of LA enantiomers with (S)-configuration reduce risk of cardiac depression and cardiotoxicity, and ropivacaine (an S-isomer) and levoupivacaine (S-bupivacaine) may have significant advantages compare to racemic bupivacaine
  • 111. Hematology --Methemoglobinemia Rare but potentially life treatening complication (decreased O2-carrying capacity) Cause by oxidation of Hb to methemoglobin more rapidly than methemoglobin is reduced by Hb Prilocaine ( > 600mg @ >10mg/kg) Amide LA that is metabolized to othotoluidine Othotoluidine is oxidizing compound, capable of converting Hb to methemoglobin ---- methemoglobinaemia Cause pt to appear cyanotic Also caused by Benzocaine ( topical application > 200-300mg) Is readily reversed by administration of iv methylene blue, 1-2mg/kg over 5 min (total dose 7-8mg/kg)
  • 112. Respiratory Lidocaine at high plasma concentration depress ventilatory response to arterial hypoxaemia So patient with CO2 retention which resting ventilation depend on hypoxic drive may be at risk of ventilatory failure when lidocaine is administered for treatment of cardiac dysrythmia
  • 113. Hepatotoxicity Continous or intermittent epidural administration of bupivacaine to treat postherpetic nuralgia has been associated with increase plasma concentration of liver transaminase enzyme that normalized when bupivacaine infusion was discontinued It could be due to a direct toxic injury or an allergic reaction Dysphoria Vivid fear of imminent death and a delusional belief of having died
  • 114. Death Toxicity 26 24 22 20 18 16 14 12 10 8 6 4 2 0 Ventricular Arrest Cardiac Arrhythmia Respiratory arrest Coma Myocardial depression Loss of conciousness Convulsion Muscle twitching CNS excitation Visual disturbances Lightheadness, tinnitus, circumoral & tongue numbness Positive inotropy, anticonvulsant, antiarrythmic Plasma lidocaine concentration µg/ml
  • 115.
  • 119.
  • 120. Presentation – clear colourless, aques solution (bupivacaine hydrochloride )
  • 122. With 1:200 000 (5µg/ml ) adrenaline
  • 123. Heavy 0.5% with 80mg/ml dextrose ( SG 1.026) used for SA
  • 124. Recommended max dose 2mg/kg, 0.75% produces more prolonged motor block
  • 125. Clinical- acts within 10-20min and almost immediate with intrathecal administration,
  • 127. 4X as potent as lidocaine, propensity for cardiotoxicity
  • 128.
  • 129.
  • 130. Excretion – 5% excreted as PPX, 16% excreted unchanged in urine, Cl 0.47L/m t½ 0.31-0.61Hr (after IV admin)
  • 131.
  • 132. Presentation – Clear colourless solution containing 0.2/ 0.75/ 1.0% ropivacaine hydrochloride
  • 133. Recommended dose –3.5mg/kg, 250mg (150mg for C-section under epidural), not currently intended for intrathecal admin and in children < 12 years
  • 134. Clinical – sensory blockade similar in time course to that produced by bupivacaine; motor blockade is slower in onset & shorter in duration than after an equivalent dose of bupivacaine; less cardiotoxic than bupivacaine; Intrinsic vasoconstrictor, mild CNS Sx
  • 135.
  • 136.
  • 137. Excretion – 86% (mostly conjugated) excreted in the urine, 1% unchanged
  • 138.
  • 139.
  • 140. Presentation – Clear aq solution lidocaine hydrochloride
  • 141. Plain 0.5%( local infiltration, IVRA ), 1%, 2%(nerve blocks, extradural anaesthesia)
  • 143. Gel 2% with or without chlorhexidine
  • 144. 4% aq solution for topical application to pharynx, larynx, trachea
  • 145. 10% spray for oral cavity & upper resp tract
  • 146. Recommended max dose 3mg/kg (7mg/kg with adrenaline), toxic plasma level >10ug/ml
  • 147. Acute ventricular dysrhythmia ( class 1)– 1mg/kg over 2 min followed by infusion 4mg/kg/min (30min), 2mg/kg/min ( 2 hr) & subsequently 1mg/kg/min.
  • 148. Reduce stress response – 1-2mg/kg IV 5min before intubation
  • 150.
  • 151.
  • 152. Excretion - <10% excreted unchangedCl – 6.8-11.6ml/kg/min t½ - 90-110min
  • 153.
  • 154. Presentation – clear colourless aq prilocaine hydrochloride
  • 156. Solution with 0.03 u/ml felypressin(3%) for dental infiltration
  • 157. EMLA
  • 158. Recommended max dose – 5mg/kg; with felypressin 8mg/kg
  • 160. rapid onset, intermediate duration between lidocaine & bupivacaine; potency similar to lidocaine; less toxic
  • 161. may be used for IVRA(0.5%); 1-2% for nerve block
  • 162. problem with metHb (>600mg IV)
  • 163.
  • 164.
  • 165.
  • 166. Restricted use to surface analgesia because of its toxicity
  • 167. Commonly used as 10% spray or paste to reduce bleeding caused by nasal intubation
  • 168. Causes vasoconstriction by preventing uptake of noradrenaline by presynaptic nerve endings, also inhibit monoamine oxidase
  • 169. Recommended dose – admin topically 3mg/kg
  • 170. Clinical – inhibit uptake of adrenaline and noradr by central and peripheral symphatetic nerve endings, and enhances effect of sympt nerve stimulation
  • 171. CNS – increased neuronal activity in symphatetic pathways in hypothalamus and medulla
  • 172. It may produce mental stimulation, euphoria, hallucinations, vasoC, pupillary dilatation, hypertension, tachycardia and arrhythmias
  • 174. Absorption – well absorb from mucosa; bioavailability-intranasal 0.5%
  • 175. Distribution – 98% protein bound, Vd 0.9-3.3L/kg
  • 176. Metabolism – degraded by plasma esterase predominantly to benzoylecgonine, ecgonine
  • 177. Excretion – metabolites excreted in urine , 10-12% unchanged Cl 26-44ml/kg/min t½ 25-60min
  • 178.
  • 179. CNS stimulation: convulsions at high doses, followed by central depression and apnoea
  • 180. Symphatetic stimulation: arrhythmias, tachycardia and hypertension may occur
  • 181. Addiction may occur with chronic use
  • 182. Cardiomyopathy and sudden death have been associated with chronic abuse
  • 183.
  • 184. Mixture of 2.5% lidocaine + 2.5% prilocaine as oil- water emulsion
  • 185. Melting point of each LA is lowered by presence of the other
  • 186. May produce blanching (addition of nitroglycerine ointment may promote venodilation) and increase in metHb (esp < 3mths- immature reductase pathway)
  • 188. Effective analgesia 60-90 min after topical application and covering with occlusive dressing
  • 189. Uses described include analgesia for venopuncture, venous and arterial cannulation, lumbar puncture, epidural injection, superficial skin surgery and relief of tourniquet pain during IVRA
  • 190.
  • 191. mcq 1. Lidocaine can cause: a) sedationb) convulsionsc) slowed A-V conductiond) prolongation of the cardiac action potentiale) shortening of the refractory phase f) Is more potent than ropivacaine
  • 192. mcq 1. Lidocaine can cause: a) sedation Tb) convulsions Tc) slowed A-V conduction Td) prolongation of the cardiac action potential Fe) shortening of the refractory phase T f) Is more potent than ropivacaine F
  • 193. 2. Regarding local anaesthetic agents (LA):a) the potency of LAs is proportional to their lipid solubilityb) the duration of action is dependent on protein bindingc) agents with low pKa have a faster onset of actiond) all local anaesthetics are vasodilatorse) the depth of local anaesthetic block is increased by increasing the dose
  • 194. 2. Regarding local anaesthetic agents (LA):a) the potency of LAs is proportional to their lipid solubility Tb) the duration of action is dependent on protein binding Tc) agents with low pKa have a faster onset of action Td) all local anaesthetics are vasodilators Fe) the depth of local anaesthetic block is increased by increasing the dose T
  • 195. 3. Concerning local anaesthetics:   a) they are absorbed more rapidly after intercostal block than after caudal administration b) in the foetus they are able to cross the placenta as readily as from the mother c) they are weak acids d) those which are esters are rapidly metabolised by liver enzymes e) pKa is the pH at which more than half of a local anaesthetic exists in non-ionised form  
  • 196. 3. Concerning local anaesthetics:   a) they are absorbed more rapidly after intercostal block than after caudal administration Tb) in the foetus they are able to cross the placenta as readily as from the mother Fc) they are weak acids Fd) those which are esters are rapidly metabolised by liver enzymes Fe) pKa is the pH at which more than half of a local anaesthetic exists in non-ionised form  F 
  • 197. 4.Cocaine: A. Blocks reuptake of dopamine and noradrenaline B. Central effects are due to noradrenaline C. Crosses lipid soluble membranes because its pKa is 2.8 D. Is not metabolised by plasma pseudocholinesterase E. Rapidly absorbed by nasal mucosa
  • 198. Cocaine: A. Blocks reuptake of dopamine and noradrenaline T B. Central effects are due to noradrenaline F C. Crosses lipid soluble membranes because its pKa is 2.8 F D. Is not metabolised by plasma pseudocholinesterase F E. Rapidly absorbed by nasal mucosa ?
  • 199. 5.Ropivacaine A. Is a pure R isomer B. Is an isomer of bupivacaine C. Provides more motor block than bupivacaine D. Has more toxicity than bupivacaine E. Has similar physico-chemical properties to bupivacaine
  • 200. 5.Ropivacaine A. Is a pure R isomer F B. Is an isomer of bupivacaine F C. Provides more motor block than bupivacaine F D. Has more toxicity than bupivacaine F E. Has similar physico-chemical properties to bupivacaine T